SiFlow (Suzhou) Biotechnology
↗Suzhou, China
SiFlow is a high-tech biotechnology company specializing in the development and manufacture of nano-scale flow cytometers. The company's core technology, developed in collaboration with leading academic institutions like Xiamen University, enables the high-throughput, multi-parameter analysis of individual nanoparticles, including extracellular vesicles (EVs), exosomes, viruses, and drug delivery vehicles.
The company's flagship products, such as the SiFlow® A50-pro, provide researchers with the ability to detect particles as small as 30-40nm, filling a critical gap in traditional flow cytometry. SiFlow serves the global life sciences market, providing tools for basic research, clinical diagnostics development, and biopharmaceutical quality control.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Life Science Tools & Diagnostics
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$10M
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Series A/B
Total Raised:$15M-$25M (Estimated)
Investors:Oriza Holdings (元禾控股), BioBAY, Xiamen University Technology Transfer Fund
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (Instrument manufacturer)
Modalities:Exosome Analysis, Lipid Nanoparticles (LNP), Viral Vector Analysis
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Xiamen University (Research Collaboration), Beckman Coulter (Distribution/Co-marketing in specific regions), Various Chinese Clinical Research Centers
COMPETITION
Position:Niche Player
Competitors:NanoFCM, Apogee Flow Systems, Beckman Coulter (CytoFLEX), Malvern Panalytical (NanoSight), Particle Metrix
LEADERSHIP
Key Executives:
Jia She - CEO
Xiaomei Yan - Scientific Founder
Scientific Founders:Prof. Xiaomei Yan
Board Members:Jia She, Representatives from Oriza Holdings
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SiFlow (Suzhou) Biotechnology. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.